APOC3 and coronary artery disorder: The fact that the genetically predicted association between APOC3 levels and CAD is primarily explained by remnant cholesterol suggests that remnant cholesterol could serve as an early biomarker to predict the cardiovascular efficacy of APOC3 therapies.